Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
9.45
-0.15 (-1.56%)
At close: Dec 26, 2025, 4:00 PM EST
9.59
+0.14 (1.48%)
After-hours: Dec 26, 2025, 7:25 PM EST
DAWN Employees
Day One Biopharmaceuticals had 181 employees as of December 31, 2024. The number of employees increased by 26 or 16.77% compared to the previous year.
Employees
181
Change (1Y)
26
Growth (1Y)
16.77%
Revenue / Employee
$738,519
Profits / Employee
-$838,442
Market Cap
970.28M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 181 | 26 | 16.77% |
| Dec 31, 2023 | 155 | 34 | 28.10% |
| Dec 31, 2022 | 121 | 66 | 120.00% |
| Dec 31, 2021 | 55 | 35 | 175.00% |
| Dec 31, 2020 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DAWN News
- 8 days ago - Day One Pharmaceuticals: Stock Surges Ahead Of Promising 2026 - I'm Bullish - Seeking Alpha
- 11 days ago - Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting - GlobeNewsWire
- 5 weeks ago - Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Day One Biopharma Expands Oncology Pipeline With $285 Million Mersana Buyout - Benzinga
- 6 weeks ago - Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases - GlobeNewsWire
- 6 weeks ago - Day One Announces New OJEMDA™ (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting - GlobeNewsWire
- 7 weeks ago - Day One Biopharmaceuticals, Inc. (DAWN) Q3 2025 Earnings Call Transcript - Seeking Alpha